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Purpose: We conducted an in vivo study using Dutch pigmented rabbit eyes to test
the usefulness of polyethylene glycol (PEG) sealant for the closure of sutureless
sclerotomies in microincisional vitrectomy surgery (MIVS).
Methods: Three-port, 23-gauge vitrectomy was performed on rabbit eyes. After air
leakage was confirmed by the application of 0.625% povidone–iodine at the
sclerotomy site, PEG sealant was subconjunctivally injected using a 27-gauge needle
through conjunctival incisions to cover the sclerotomy wounds, following which it
was polymerized by the application of xenon light for 60 seconds. Ophthalmological
examinations and intraocular pressure measurements were conducted the day before
and 1, 3, 5, and 7 days after surgery. The eyes were enucleated for histological
evaluation 7 days after surgery.
Results: PEG sealant was rapidly polymerized by the application of xenon light after
subconjunctival injection, and it firmly sealed the sclerotomies without air leakage, as
confirmed by povidone–iodine dropping, in all cases. Conjunctival and scleral wounds
closed with PEG sealant were successfully attached and remained intact till the end of
the follow-up period. There was no sign of postoperative hypotony or infection in any
eye, and no adverse effects of PEG sealant were found. In histological examination,
linear scar formation and eosinophilic staining of collagen fibers were observed at the
sclerotomy sites, while the sclerotomy tunnels appeared tightly closed.
Conclusions: PEG sealant can be useful for the closure of sutureless 23-gauge
vitrectomy incisions in rabbits.
Translational Relevance: The PEG sealant may become an effective option for
closing vitrectomy incisions including pediatric cases.
Introduction
Microincisional vitrectomy surgery (MIVS) has
gained acceptance by vitreoretinal surgeons world-
wide since its introduction. The indications for MIVS
have expanded to include conditions involving the
most posterior segment, because the instrumentation
for this procedure has been improved to rival that of
traditional 20-gauge vitrectomy. Sutureless MIVS
offers clear advantages to the patient, including a
decreased procedural duration,1,2 quicker visual
recovery from decreased corneal astigmatism and
higher-order abberations,3 less anterior segment
inflammation,2 less postoperative discomfort, and
early patient rehabilitation.1,2 However, potential
adverse postoperative events such as early hypotony
and endophthalmitis remain issues of concern.4–6
Endophthalmitis and hypotony are attributed to
the entry of ocular surface fluid or leakage of
intraocular fluid via the vitrectomy incisions in the
early postoperative period. Surgeons recognize this as
a possible limitation of MIVS. According to the 2009
American Society of Retina Specialists (ASRS)
Preferences and Trends survey, 36% of the retinal
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surgeon respondents sutured at least one of the
sclerotomies in 23-gauge vitrectomy 1% to 25% of
the time, while 15% respondents placed a suture 26%
to 50% of the time. Duval et al.7 reviewed 589 eyes
that were subjected to primary 23-gauge vitrectomy
and found that at least one sclerotomy was sutured
in 227 eyes (38.5%). However, suture placement
prolongs the surgical duration, induces corneal
astigmatism, and possibly delays visual recovery.
Furthermore, the foreign body sensation provided
by sutures compromises patient comfort. In pediatric
vitrectomy, postoperative hypotony due to wound
leakage is a matter of concern, and wound closure
with sutures is required in pediatric eyes because of a
more elastic sclera compared with that in adults. If
the wound shows postoperative leakage, the child
will have to undergo an additional wound repair
surgery under general anesthesia.
In order to overcome potential complications
related to wound leakage, wound closure with
sutures, cyanoacrylate glue, tissue fibrin glue, and
other complex adhesives has been attempted.8,9 It
seems reasonable to use tissue adhesives as an
alternative to sutures for scleral closure in order to
avoid the abovementioned suture-related problems.
Although cyanoacrylate and fibrin glue have been
used, each has its drawbacks such as heat production,
friability, theoretical risk of anaphylaxis, and disease
transmission.8,9
In situ polymerizing synthetic polymers containing
synthetic polyethylene glycol (PEG) have been
approved for use as dura mater sealants, lung
sealants, and abdominopelvic adhesion barriers.
These compounds can be engineered to form adherent
hydrogel coatings with varying absorption abilities,
consistency, and flexibility depending on the indica-
tion for use. We designed and conducted an in vivo
study using Dutch pigmented rabbit eyes to test a
PEG-based synthetic hydrogel (PEG sealant) as a
sealant to close sutureless sclerotomies in MIVS.
Materials and Methods
PEG Sealant
FocalSeal (Genzyme Corporation, Cambridge,
MA), which has been approved by the US Food
and Drug Administration (FDA) as a sealant to limit
air leakage following pulmonary resection, is an
absorbable PEG-based synthetic hydrogel that can
be polymerized by visible illumination from a xenon
arc lamp (450–500 nm, blue green) for 40 to 60
seconds to form a clear, flexible, and firmly adherent
hydrogel that can seal air and fluid leaks.10,11 This
material is absorbed over a 1- to 6-month period into
water-soluble substances that are subsequently ex-
creted by the body.10,12,13
Vitrectomy
Six pigmented Dutch rabbits (weight, 2.0–3.0 kg;
Kitayama Labes Ltd., Nagano, Japan) were used in
our study. We followed all applicable institutional
and governmental regulations concerning the ethical
use of animals. The study conformed to the ARVO
Statement for the Use of Animals in Ophthalmic and
Vision Research. All procedures were performed in
the right eye of the animals using sterile techniques.
The animals were anesthetized with intramuscular
injection of ketamine hydrochloride (35 mg/kg) and
xylazine (5 mg/kg). Topical anesthesia (0.4% oxy-
buprocaine hydrochloride drops) was also applied to
the eyes. The pupils were dilated with topical 0.5%
phenylephrine hydrochloride, 0.5% tropicamide, and
1% atropine.
An experienced vitreoretinal surgeon (FO) per-
formed lensectomy and three-port, 23-gauge vitrecto-
my in the right eye of the study animals. The 23-gauge
two-step Eckardt vitrectomy system (DORC, Zuid-
land, the Netherlands) uses a microvitreoretinal
(MVR) blade to place a scleral incision, following
which the trocar cannula is inserted.
The conjunctiva was prepared using 5% povidone–
iodine solution. Following lens removal (phacoemul-
sification technique) through an approximately 3-mm
sclerocorneal incision, the wound was sutured with
10-0 nylon suture (Mani Nylon; Mani, Tochigi,
Japan). For vitrectomy, the incision site was marked
on the conjunctiva at a distance of 1 mm from the
corneal limbs. The conjunctiva was laterally displaced
by forceps, and the MVR blade was applied on the
globe at an angle of 458 to the surface of the eye. It
was then advanced in an oblique direction, 1 mm
from the bevel margin, and perpendicularly lifted to
enter the vitreous in a direction pointing toward the
center of the globe. The trocar cannula of the two-
step system was inserted after the sclerotomies were
complete. Three sclerotomies were created using the
above described procedure.
A vitreous cutter, endoilluminator optical fiber,
and infusion tip were respectively placed in the three
sclerotomies. A flat-concave contact lens was placed
on the cornea and vitrectomy was performed under a
surgical microscope. Triamcinolone acetonide was
used to visualize the vitreous body, and posterior
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vitreous detachment was induced. The vitreous body
around the trocar cannulae was carefully removed to
eliminate the possibility of vitreous incarceration.
After the vitreous body was removed, sterilized air at
a pressure of 30 to 35 mm Hg was continuously
pumped into the eye via the infusion tip to exchange
the intraocular equilibrium liquid.
The three sclerotomies were termed infusion scle-
rotomy (involving the use of an infusion tip), experi-
mental sclerotomy, and contralateral sclerotomy. The
cannulae for experimental sclerotomy were removed
and air leakage confirmed by the application of 0.625%
povidone–iodine at the sclerotomy site. Then, 0.05 to
0.1 mL of PEG sealant was subconjunctivally injected
through conjunctival incisions using a 27-gauge needle
to cover the experimental sclerotomy wounds, follow-
ing which it was polymerized by the application of light
(420- to 700-nm wavelength) from a xenon light source
(Accurus Xenon Illuminator; Alcon, Fort Worth, TX)
for 60 seconds. The experimental sclerotomy wound
was checked again for leakage at the sclerotomy site by
dropping 0.625% povidone–iodine (Fig. 1). Then, the
cannula at the contralateral sclerotomy site was
removed and the wound was closed using 8-0 vicryl
sutures (Coated VICRYL [polyglactin 910]; Ethicon
Inc., Somerville, NJ). The air pressure via the infusion
tip was gradually increased until air leakage was
observed by dropping 0.625% povidone–iodine at the
experimental or contralateral sclerotomy sites; this was
done in only one of the six rabbits to evaluate how
tightly the scleral wound was closed after PEG sealant
application.
The infusion sclerotomy wound was then closed
using 8-0 vicryl sutures after removal of the cannula
connected to the infusion tip. Following the surgery,
0.1% betamethasone and 1.5% levofloxacin were
applied three times a day for 7 days.
Ophthalmologic Examination
Slit-lamp microscopy and funduscopy by indirect
ophthalmoscopy were performed after pupil dilata-
tion the day before and 1, 3, 5, and 7 days after
surgery. The bilateral intraocular pressure was
measured using a rebound tonometer (Icare Pro;
Icare Finland Oy, Helsinki, Finland) the day before
and 1, 3, 5, and 7 days after surgery. A two-tailed
paired t-test was used for statistical analysis to
examine the relationship between the operated and
contralateral eyes.
Histology
Rabbits were sacrificed with an overdose of
pentobarbital 7 days after surgery, and their eyes
were enucleated. After enucleation, the sclerotomy
sites covered with PEG sealant were excised and fixed
in 2% paraformaldehyde and 2.5% gluteraldehyde
solution, dehydrated with serial alcohols, and embed-
ded in paraffin. Sections were cut with a thickness of 4
lm, stained with hematoxylin and eosin, and exam-
ined under a light microscope.
Figure 1. Diagram of the process for sealing scleral incisions with
PEG sealant. (A, B) After cannula removal and confirmation of air
leakage at a sclerotomy site, PEG sealant is subconjunctivally
injected using a 27-gauge needle through conjunctival incisions to
cover the sclerotomy. (C) PEG sealant is polymerized by 60-second
application of xenon light over the conjunctiva.
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Results
Before sealing the experimental sclerotomies with
PEG sealant, air bubbles from the scleral incisions at all
sites were observed when povidone–iodine was dropped
on the wounds, confirming air leakage. After applica-
tion, PEG sealant was rapidly polymerized by the
application of xenon light after subconjunctival injec-
tion. Following this, no air leakage was observed when
povidone-iodine was dropped in all cases (Fig. 2). When
the air pressure was increased to 90 mm Hg, air leakage
was observed at the contralateral sclerotomy site
sutured with 8-0 vicryl, while the experimental sclerot-
omy site closed with PEG sealant remained secure.
In anterior segment examination, conjunctival
hyperemia was observed in all eyes on the first
postoperative day. Conjunctival and scleral wounds
closed with PEG sealant were successfully attached
and remained intact till the end of the follow-up
period. Conjunctival bleb formation was not observed
on the conjunctival surface at the sclerotomy sites
during and after surgery. Mild intraocular inflamma-
tion was present on the first postoperative day, which
resolved within 7 days. There was no sign of
postoperative hypotony or infection in any eye, and
no adverse effects of PEG sealant were encountered.
Table 1 shows the mean intraocular pressure in the
operated and contralateral eyes before and 1, 3, 5, and
7 days after surgery; there were no significant
differences between the two sets of eyes throughout
the observation period.
In histological examination, three of six scleroto-
mies were identified. Linear scar formation and
eosinophilic staining of collagen fibers were observed
at the sclerotomy sites, while the sclerotomy tunnels
appeared tightly closed (Fig. 3). PEG sealant was not
identified in any specimen.
Discussion
PEG sealant is an absorbable PEG-based synthetic
hydrogel. The liquid is polymerized under visible
xenon illumination and forms a clear, flexible, and
firmly adherent hydrogel. In our in vivo study, PEG
sealant was easily delivered into the subconjunctival
sclerotomy sites using a 27-gauge needle through
conjunctival incisions and rapidly photopolymerized
in a flexible mass by the application of xenon light,
resulting in the successful sealing of sutureless 23-
gauge vitrectomy incisions in rabbits.
In order to overcome potential complications
related to wound leakage from sclerotomies, wound
closure with cyanoacrylate glue, tissue fibrin glue, and
other complex adhesives has been suggested.8,9 Cya-
noacrylate glue is used during corneal procedures in
some cases; however, it produces heat and settles
rapidly into an inflexible and friable material. It should
be recognized that patients may experience discomfort
caused by the rough and dry surface of the glue on the
ocular surface when it used for sealing sclerotomies.
Furthermore, cyanoacrylate was reported to cause
direct tissue toxicity, which is another limitation.14
Tissue fibrin glue (Tisseel; Baxter AG, Vienna,
Austria) was used as an alternative to sutures in a
small series of patients who underwent surgery for the
closure of MIVS and 20-gauge vitrectomy incisions.15
Unlike cyanoacrylate glue, fibrin glue forms a smooth
seal rather than a hard mass, thus providing greater
postoperative comfort with fewer complications.16
Although it is nontoxic to the tissue and is less likely
to cause a foreign body reaction, fibrin glue carries
the theoretical risk of anaphylaxis and disease
transmission.15
In this experiment, we tested the ability of PEG
sealant to close 23-gauge vitrectomy incisions. PEG is
widely used in the pharmaceutical industry because of
its low toxicity and impressive safety profile, although
a PEG-induced anaphylatic reaction has been report-
ed.17 Many ophthalmic products, including lubricant
eye drops, ophthalmic corticosteroids, ocular decon-
gestants, and artificial tears, also contain this
chemical. The hydrogel comprises approximately
95% water, with PEG cross-linked with trilysine as
solid components. The link between each PEG and
trilysine molecule contains a hydrolysable segment.
Therefore, in the months following implantation, the
hydrogel gradually weakens and liquefies, releasing
the individual PEG and trilysine molecules. Hydro-
lysable linkages between the PEG molecules cause the
Table 1. The Mean Intraocular Pressure (mm Hg) in
the Operated and Contralateral Eyes before and 1, 3, 5,
and 7 Days after Surgery
Operated
Eyes
Contralateral
Eyes
Paired
t-test
Before surgery 8.0 6 0.9 7.7 6 0.8 NS
After surgery
1 d 8.7 6 1.1 7.6 6 0.6 NS
3 d 8.8 6 1.5 7.8 6 0.9 NS
5 d 8.1 6 1.5 7.3 6 1.3 NS
7 d 8.0 6 1.1 8.1 6 1.5 NS
NS, not significant.
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hydrogel to liquefy within approximately 2 months.
This gel degradation process is solely dependent on
the presence of water and is not affected by enzymes.
Trilysine is a product of L-lysine synthesis, which
plays an important role in the formation of collagen
and is a naturally occurring essential amino acid. The
PEG and trilysine molecules are rapidly absorbed and
cleared from the body via renal filtration.
Figure 2. Photographs showing closure of a scleral incision using PEG sealant in a rabbit vitrectomy model. (A) After vitreous body
removal and fluid–air exchange, the cannula is removed. The arrow indicates the conjunctival incision placed after cannula removal. (B)
Air leakage, evident by the appearance of air bubbles from the scleral incisions, is confirmed by pouring 0.625% povidone-iodine at the
sclerotomy site. (C) PEG sealant is subconjunctivally injected using a 27-gauge needle through conjunctival incisions to cover the
sclerotomy. (D) PEG sealant is rapidly polymerized by the application of xenon light. The sclerotomy is closed. (E) No air leakage is
observed when povidone-iodine is poured at the sclerotomy site.
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Singh et al.18 conducted a laboratory study to
evaluate the ability of the hydrogel bandage (ReSure
Ocular Bandage; Ocular Therapeutix, Inc., Bedford,
MA) to seal sutureless pars plana vitrectomy sclerot-
omies performed on human globes procured from an
eye bank.18 The incisions received either a hydrogel
device, a suture, or neither and were evaluated for the
ingress of India ink. The bandage prevented the entry
of ink particles in all covered incisions (11 of 11). One
sutured eye (1 of 5) and four control eyes (4 of 5)
permitted the ingress of ink through the incision. In a
separate study with a different set of human cadaveric
eyes, hydrogel sealant resulted in a secure, watertight
seal for sutureless 23-gauge vitrectomy incisions.19 In
that in vitro experiment, the outcomes were considered
equivalent to those achieved with sutures. Laboratory
experiments showed that the hydrogel seal was
sufficiently strong and maintained ocular integrity at
intraocular pressures beyond those experienced by the
globe during eyelid blinking, eye rubbing, coughing, or
eyelid squeezing.20 However, these experiments are
limited by their in vitro nature, and it remains unclear
whether PEG-based synthetic hydrogel bandage suc-
cessfully closes sutureless 23-gauge vitrectomy incisions
in vivo. Furthermore, the hydrogel sealant used by the
previous authors requires mixing of two phases to
initiate a cross-linking reaction before application.
Also, the sealants were applied to the sclerotomies
using a foam-tipped applicator and in the absence of
conjunctiva; this does not simulate the actual clinical
setting, where conjunctiva will also be present.18,19
To the best of our knowledge, this is the first in vivo
experiment on the effectiveness of PEG-based synthetic
hydrogel as a sealant for sclerotomy in MIVS. Because
PEG sealant is a photocurable and single-phase gel
that does not require prior mixing, it was easily
delivered using a 27-gauge needle through conjunctival
incisions and photopolymerized with xenon intraocular
illumination, which is used in routine opthalmological
surgeries. Our in vivo experiment indicated that PEG
sealant was sufficiently strong and maintained ocular
integrity throughout the observation period.
In ophthalmologic examination and histological
evaluation, no adverse effects of PEG sealant on the
ocular tissue were observed, with no signs of increased
intraocular inflammation. It only induced a mild to
moderate local inflammatory reaction, which is
considered acceptable. We previously described that
PEG sealant was nontoxic to rabbit eyes in vivo.21
In our histological examination, PEG sealant
Figure 3. Photomicrographs of sections obtained from a sclerotomy site closed with PEG sealant. Connective tissue and collagen fibers
can be observed in the scleral gap (arrowhead). The arrow indicates the conjunctival incision. There is no evidence of excessive
inflammation, foreign body reaction, or toxic effects. Bar: 500 lm.
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tightly closed the sclerotomy through fibrosis and
collagen formation. Histological evaluations have
shown that PEG sealant effectively adheres to tissues
in other organs. Ranger et al.10 used PEG sealant for
pulmonary air leaks in dog models and observed
complete healing with a fibrotic layer overlying the
area of the pulmonary defect in their histological
examination. Alleyne et al.13 used PEG sealant as a
dural sealing material in a canine craniotomy model
and showed healing of the cut dural edges by the
formation of a bridging fibrous and collagenous scar
in their histological examination.
The limitations of this study include the relatively
short observation period, because of which the long-
term effects of the sealant remain unknown. Further
studies with long-term observation periods are thus
necessary. Because the thin sclera of rabbits was
assessed in the current study, further studies with
suitable models such as the pig eye or the human
cadaveric eye are required to more precisely evaluate
the effectiveness of PEG sealant in vitrectomy wound
closure. In addition, the irritant effects of PEG
sealant application to scleral wounds remain un-
known in this animal study, as do the effects of
blinking on the adherence of the sealant. It remains
unknown whether PEG sealant will have similar
disadvantages when sutures are used in humans.
Further studies should clarify these issues.
In conclusion, we demonstrated the ability of PEG
sealant, which is a PEG-based synthetic hydrogel, to
successfully close sutureless 23-gauge vitrectomy
incisions in rabbits. The material can be useful for
pediatric vitrectomy because it precludes the require-
ment for suturing.
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